The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients.

While this variant is rare in the AA population (~0.2% MAF), its ancestry-specific occurrence and apparent preferential association with risk for the more aggressive disease at an early age emphasizes its translational potential as an important, novel PCa susceptibility marker in the high-risk AA population.